• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020-2021

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2023 Jul 26;29(9).
doi: 10.3201/eid2909.230142. Online ahead of print.
COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020-2021

Christine J Atherstone, Sarah Anne J Guagliardo, Anthony Hawksworth, Kevin O'Laughlin, Kimberly Wong, Michelle L Sloan, Olga Henao, Carol Y Rao, Peter D McElroy, Sarah D Bennett
Free article Abstract

The SARS-CoV-2 Delta variant, first identified in October 2020, quickly became the dominant variant worldwide. We used publicly available data to explore the relationship between illness and death (peak case rates, death rates, case-fatality rates) and selected predictors (percentage vaccinated, percentage of the population >65 years, population density, testing volume, index of mitigation policies) in 45 high-income countries during the Delta wave using rank-order correlation and ordinal regression. During the Delta-dominant period, most countries reported higher peak case rates (57%) and lower peak case-fatality rates (98%). Higher vaccination coverage was protective against peak case rates (odds ratio 0.95, 95% CI 0.91-0.99) and against peak death rates (odds ratio 0.96, 95% CI 0.91-0.99). Vaccination coverage was vital to preventing infection and death from COVID-19 during the Delta wave. As new variants emerge, public health authorities should encourage the uptake of COVID-19 vaccination and boosters.

Keywords: COVID-19; COVID-19 testing; SARS-CoV-2; coronavirus disease; demographic factors; epidemiology; morbidity; mortality; population density; primary prevention; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccination coverage; viruses; zoonoses.

 
Back
Top Bottom